Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisavet Moutzouri

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|January 5, 2013
Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectivesElisavet Moutzouri, Vasilis Tsimihodimos, Alexandros D Tselepis
Archives of Medical Science : AMS|February 1, 2012
Life-threatening hypophosphataemia in a cirrhotic patient with jaundiceElisavet Moutzouri, Evangelos N Liberopoulos, Moses Elisaf
Current Vascular Pharmacology|July 15, 2010
HypocholesterolemiaElisavet Moutzouri, Moses Elisaf, Evangelos N Liberopoulos
European Journal of Pharmacology|October 25, 2011
Prediabetes: to treat or not to treat?Elisavet Moutzouri, Vasilis Tsimihodimos, Evangelos Rizos, et al.
Revue Medicale Suisse|March 5, 2026
[Controversies in familial dyslipidemias and cardiovascular genetics in 2026]Maximilien Fleury, Elisavet Moutzouri, Baris Gencer, et al.
CNS Spectrums|April 15, 2014
Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidenceElisavet Moutzouri, George Daios, Moses Elisaf, et al.
International Journal of Hypertension|July 13, 2011
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized StudyAnastazia Kei, Moses Elisaf, Elisavet Moutzouri, et al.
Vascular Health and Risk Management|August 24, 2010
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acidElisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 28, 2012
Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levelsElisavet Moutzouri, Evangelos N Liberopoulos, Matilda Florentin, et al.
Revue Medicale Suisse|March 6, 2020
[Treatment of subclinical hypothyroidism : an update of the evidence and the new Rapid Recommendations]Camilla Janett-Pellegri, Elisavet Moutzouri, Pauline Darbellay Farhoumand, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|January 5, 2013
Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectivesElisavet Moutzouri, Vasilis Tsimihodimos, Alexandros D Tselepis
Archives of Medical Science : AMS|February 1, 2012
Life-threatening hypophosphataemia in a cirrhotic patient with jaundiceElisavet Moutzouri, Evangelos N Liberopoulos, Moses Elisaf
Current Vascular Pharmacology|July 15, 2010
HypocholesterolemiaElisavet Moutzouri, Moses Elisaf, Evangelos N Liberopoulos
European Journal of Pharmacology|October 25, 2011
Prediabetes: to treat or not to treat?Elisavet Moutzouri, Vasilis Tsimihodimos, Evangelos Rizos, et al.
Revue Medicale Suisse|March 5, 2026
[Controversies in familial dyslipidemias and cardiovascular genetics in 2026]Maximilien Fleury, Elisavet Moutzouri, Baris Gencer, et al.
CNS Spectrums|April 15, 2014
Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidenceElisavet Moutzouri, George Daios, Moses Elisaf, et al.
International Journal of Hypertension|July 13, 2011
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized StudyAnastazia Kei, Moses Elisaf, Elisavet Moutzouri, et al.
Vascular Health and Risk Management|August 24, 2010
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acidElisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 28, 2012
Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levelsElisavet Moutzouri, Evangelos N Liberopoulos, Matilda Florentin, et al.
Revue Medicale Suisse|March 6, 2020
[Treatment of subclinical hypothyroidism : an update of the evidence and the new Rapid Recommendations]Camilla Janett-Pellegri, Elisavet Moutzouri, Pauline Darbellay Farhoumand, et al.
Pageof 7